COPD Trial, Recruiting NCT06188065 Sponsor: Northumbria Healthcare NHS Foundation Trust Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06188065
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to hospital with a flare-up of COPD (a lung condition often caused by smoking) as their main diagnosis
  • People who have a smoking history of at least 10 pack years (this is a measure of how much someone has smoked over time — confirm with trial site if unsure how this applies)
  • People who have confirmed airflow blockage in their lungs, shown by a specific breathing test result (called FEV1/FVC ratio below 0.7), either from a past test or one done during the hospital stay
  • People who are able to understand and agree to take part in the trial by giving informed consent

Who may not be able to join:

  • People who have a parasitic infection, a serious fungal infection (not including nail or skin infections), or certain conditions that cause high levels of a type of blood cell called eosinophils (such as eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome)
  • People who currently have an active cancer
  • People who regularly take steroid tablets (such as prednisolone) or other systemic steroids, or who take medications that affect eosinophil levels (including a type of treatment called anti-interleukin 5 therapy)
  • People who have poor vein access, making blood draws difficult
  • People who have a confirmed history of asthma, as determined by the trial investigator
  • People who have other health conditions (unrelated to COPD) that the lead investigator believes could interfere with the study being carried out properly

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen Bourke, MBChB, PhD, Northumbria Healthcare NHS Foundation Trust

Phone: 0191 293 4351

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Northumbria Healthcare NHS Foundation Trust
Registry
ClinicalTrials.gov
Start date
22 January 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Indices independently associated with eosinopenia on admission in patients with a severe exacerbation of COPD.; The time taken for BEC to recover to stable state following a severe exacerbation of COPD.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov